NCT06398353

Brief Summary

Primary headache is one of the most common neurological diseases in modern society, which seriously affects the patient's quality of life. Although the use of painkillers can alleviate primary headache symptoms, it may also cause drug dependence. Therefore, alternative therapies that do not rely on drugs have attracted increasing attention in recent years. Among them, acupuncture has been partially recognized by the public as an effective treatment for primary headaches. However, there is currently no scientific evidence that acupuncture is effective for primary headaches. The purpose of this project is to verify the effect of acupuncture in treating primary headaches. This study has three sub-projects: Subproject 2 explores the impact of acupuncture on headache severity and quality of life in patients with primary headaches. We evaluate the quality of life before and after acupuncture treatment through professional questionnaires, including the Numerical rating scale (NRS), headache diary, depression, anxiety and stress scale (DASS-21), health quality of life measurement questionnaire, Migraine Disability Assessment Scale and SF-36 Taiwan version. Finally, these data will be combined with the pulseway analysis from the results of sub-project 1 to provide a comprehensive way to evaluate the treatment effect.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
25mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Jan 2024May 2028

Study Start

First participant enrolled

January 31, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 3, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2028

Last Updated

May 7, 2024

Status Verified

January 1, 2024

Enrollment Period

3.3 years

First QC Date

March 18, 2024

Last Update Submit

May 5, 2024

Conditions

Keywords

HeadacheMigraine

Outcome Measures

Primary Outcomes (6)

  • Numerical rating scale

    Numerical rating scale (NRS) is the most commonly used pain intensity assessment tool at home and abroad. A straight line that is actually 10 centimeters, marked with "0" on the far left and "10" on the far right. Explain to the patient that "0" means no pain and "10" means very painful. The pain level increases from left to right, so that the patient can Draw vertically with a pen a few centimeters where the pain feels and record it in centimeters. You can also simply explain to the patient orally the meaning represented by "0" to "10" and let the patient rate it (verbal rating).

    2 minutes

  • The Depression, Anxiety and Stress Scale (DASS-21),

    The Depression, Anxiety and Stress Scale (DASS-21), also known as the "Self-Rating Emotion Scale" is a self-report scale that effectively assesses depression, anxiety and stress levels of the general population; it has 21 questions in total and takes time About 5 minutes. Although this scale cannot replace professional clinical diagnosis, nor can it be used as a basis for diagnosis alone, it has a significant screening effect on minor mental health problems.

    7minutes

  • Europe health-related quality of life questionnaire 5 dimensions (EQ-5D)

    Europe health-related quality of life questionnaire 5 dimensions (EQ-5D) is a preference-based health life quality measurement tool. It includes 5 self-classifier questions and 0 - Two parts including a 100-point self-assessment scale for current health status.

    7minutes

  • The headache diary

    The headache diary is to record your own headache diary every day, which can make it easier to communicate with the doctor about your pain condition and help the doctor treat primary headaches.

    20minutes

  • Migraine Disability Assessment Questionnaire (MIDAs)

    Migraine Disability Assessment Questionnaire (MIDAs) In 1999, Stewart and Lipton proposed the Migraine Disability Assessment Questionnaire (MIDAs). This scale mainly consists of five questions, asking the patient to recall the impact of migraine on schoolwork or work, household affairs, and family, social or leisure activities during the past three months. This questionnaire is also used in Japan, Upper Turkey, Italy and other countries because it is simple and easy to use and has good reliability, validity and objectivity evaluation.

    7minutes

  • The Taiwan Short Form 36 Health Scale (SF-36)

    The Taiwan Short Form 36 Health Scale (SF-36) is a widely used health-related quality of life questionnaire and is also used by people with different cultural backgrounds. Research results show that SF36 has been proven to have good reliability and validity regardless of the diagnosis, age, and gender of the test subjects, and it can also sensitively detect changes before and after treatment without falling. Therefore, this study uses SF36 as the outcome measurement tool for this study.

    20minutes

Study Arms (2)

acupuncture

EXPERIMENTAL
Other: Real acupunctureOther: Sham acupuncture

sham acupuncture

SHAM COMPARATOR
Other: Real acupunctureOther: Sham acupuncture

Interventions

Real acupuncture twice a week for two weeks

acupuncturesham acupuncture

Sham acupuncture twice a week for two weeks

acupuncturesham acupuncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willing to sign a written subject consent form
  • Male or female over 18 years old
  • Those who have headaches (for example: dizziness, heavy head, dizziness, head fullness, migraine), those who have headaches more than twice a week, and whose NRS score is ˃ 4.
  • Headache definition: Headache symptoms are classified according to the ICHD-3 headache classification of the International Headache Organization, and are mainly primary headaches.
  • Exclusin Criteria
  • Pregnant women
  • Various acute and chronic infectious diseases, various skin ulcers, sores, burns, etc.
  • The patient has injuries to the radial artery or wrist, or has steel nails, plates, or fractures.
  • Various types of headaches related to anatomical structural lesions
  • Headaches associated with taking or withdrawing from substances (drugs, food, or other chemicals)
  • Headaches related to non-head infections and metabolic diseases
  • People with painful cranial neuropathy, other facial pain and other headaches
  • People with secondary headaches according to ICHD-3 beta

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, Select A State, 333323, Taiwan

RECRUITING

MeSH Terms

Conditions

Migraine DisordersHeadache

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Chien-Chung YANG

    Chang Gung Memorial Hospital

    STUDY DIRECTOR

Central Study Contacts

Chien-Chung YANG

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2024

First Posted

May 3, 2024

Study Start

January 31, 2024

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

May 31, 2028

Last Updated

May 7, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations